These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1326203)

  • 21. Nerve damage in leprosy and its management.
    Wilder-Smith EP; Van Brakel WH
    Nat Clin Pract Neurol; 2008 Dec; 4(12):656-63. PubMed ID: 19002133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. III. Neural and other impairments.
    Schreuder PA
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):170-81. PubMed ID: 9728449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological case definitions of peripheral neuropathy: experience from two neurotoxicity studies.
    Gerr F; Letz R
    Neurotoxicology; 2000 Oct; 21(5):761-8. PubMed ID: 11130280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study.
    Papanas N; Giassakis G; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Piperidou H; Maltezos E
    J Diabetes Complications; 2007; 21(6):353-8. PubMed ID: 17967706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Silent neuropathy in patients with leprosy in the city of Fortaleza, Ceará State, Brazil].
    Leite VM; Lima JW; Gonçalves Hde S
    Cad Saude Publica; 2011 Apr; 27(4):659-65. PubMed ID: 21603749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unexplained delayed nerve impairment in leprosy after treatment.
    Rosenberg NR; Faber WR; Vermeulen M
    Lepr Rev; 2003 Dec; 74(4):357-65. PubMed ID: 14750581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathological and clinical findings in leprosy patients with chronic neuropathic pain: a study from Hyderabad, India.
    Lund C; Koskinen M; Suneetha S; Lockwood DN; Haanpää M; Haapasalo H; Hietaharju A
    Lepr Rev; 2007 Dec; 78(4):369-80. PubMed ID: 18309711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the four simple methods in the diagnosis of diabetic peripheral neuropathy].
    Jia WP; Shen Q; Bao YQ; Lu JX; Li M; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2707-10. PubMed ID: 17199983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurological manifestations of Hansen's disease and their management.
    Agrawal A; Pandit L; Dalal M; Shetty JP
    Clin Neurol Neurosurg; 2005 Oct; 107(6):445-54. PubMed ID: 16202816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensory testing using neurothesiometry.
    Cassella J; Ashford RL
    Lepr Rev; 2000 Mar; 71(1):84-5. PubMed ID: 10820994
    [No Abstract]   [Full Text] [Related]  

  • 31. A scale to assess the severity of leprosy reactions.
    Van Brakel WH; Nicholls PG; Lockwood DN; Rao PS; Smith WC
    Lepr Rev; 2007 Jun; 78(2):161-4. PubMed ID: 17824489
    [No Abstract]   [Full Text] [Related]  

  • 32. Histological changes in the nerve, skin and nasal mucosa of patients with primary neuritic leprosy.
    Suneetha S; Arunthathi S; Kurian N; Chacko CJ
    Acta Leprol; 2000-2001; 12(1):11-8. PubMed ID: 11526636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Guideline for neurologic examination of leprosy].
    Abe M; Arakawa I; Iwata M; Uono K; Ota N
    Nihon Rai Gakkai Zasshi; 1982; 51(3):161-70. PubMed ID: 6313589
    [No Abstract]   [Full Text] [Related]  

  • 34. Technology literature review: quantitative sensory testing.
    Chong PS; Cros DP
    Muscle Nerve; 2004 May; 29(5):734-47. PubMed ID: 15116380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does loss of nerve function equal pure neuritic leprosy?
    Butlin CR
    Lepr Rev; 1995 Sep; 66(3):257-8. PubMed ID: 7500824
    [No Abstract]   [Full Text] [Related]  

  • 36. The prognostic importance of detecting mild sensory impairment in leprosy: a randomized controlled trial (TRIPOD 2).
    Van Brakel WH; Anderson AM; Withington SG; Croft RP; Nicholls PG; Richardus JH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):300-10. PubMed ID: 14750575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ulnar and median nerves in paucibacillary leprosy--a follow-up study of electrophysiological functions in patients before and after nerve trunk decompression.
    Husain S; Kumar A; Yadav VS; Malaviya GN
    Lepr Rev; 2003 Dec; 74(4):374-82. PubMed ID: 14750583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3).
    Richardus JH; Withington SG; Anderson AM; Croft RP; Nicholls PG; Van Brakel WH; Smith WC
    Lepr Rev; 2003 Dec; 74(4):311-8. PubMed ID: 14750576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The paper grip test for screening on intrinsic muscle paralysis in the foot of leprosy patients.
    de Win MM; Theuvenet WJ; Roche PW; de Bie RA; van Mameren H
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):16-24. PubMed ID: 12120036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Peripheral neuropathy in the elderly].
    Le Forestier N; Bouche P
    Psychol Neuropsychiatr Vieil; 2006 Jun; 4(2):109-19. PubMed ID: 16753584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.